Physician profile
Steven C Eldenburg
NPI 1689662744
$3,788.00
in general payments reported to CMS, 2019-2025
38 companies · $1,011 in 2025
The $1,011 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $864 · 2020: $340 · 2021: $157 · 2022: $141 · 2023: $588 · 2024: $688 · 2025: $1,011.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,243 · Education: $43.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,242.79 |
| Education | $43.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $696.32 | 2021-2025 | |
| Novo Nordisk INC | $454.75 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $317.54 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $305.65 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $304.74 | 2019-2025 | Repatha, Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $171.79 | 2023-2025 | |
| Allergan, INC. | $141.31 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $98.84 | 2019-2023 | Xifaxan |
| Exact Sciences Corporation | $91.66 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $85.81 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $83.87 | 2019-2023 | Qelbree |
| Lundbeck LLC | $83.58 | 2024-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $75.38 | 2019-2024 | Trintellix |
| Viatris Specialty LLC | $73.53 | 2025 | Yupelri |
| Dexcom, INC. | $71.79 | 2024-2025 | Dexcom G6 Transmitter |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Eldenburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.